Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Aug 09, 2020 2:48am
122 Views
Post# 31383993

RE:RE:The next week will be monumental.

RE:RE:The next week will be monumental. Yike the word monumental.  That word scares me when it comes to this stock.

I to have been waiting for Q2 and putting that word monumental out there will give me nightmares of previous vanishing $30M talk.

At this point with what is going on the "monumental" thing we need is some revenue.  Not an absolute ton but some but the bigger thing is a true update on what they have been doing, maybe a forecast of what they did in July as its not part of Q2 but they shoudl have a rough idea, and some kind of good news.  Dont let the big cat out of the bag but we need something.  This cannot sit at $0.065 and $0.055 for another 4 months.
<< Previous
Bullboard Posts
Next >>